SNHG6 203 Transcript Could be Applied as an Auxiliary Factor for more Precise Staging of Breast Cancer

Document Type: Original Article

Authors

1 Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran

2 Genetic division, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran

Abstract

Background: Nowadays long non-coding RNAs are known as interesting functional part of the transcriptome. LncRNA SNHG6 was reported to be expressed more in breast cancer tissues than non-tumor ones. As a frequent cancer among women, breast cancer treatment needs applied biomarkers for fast prognosis and diagnosis. SNHG6 RNA and its splice variants could be considered as molecular biomarkers for the breast cancer well-timed treatment.
Methods: RNA extraction from 35 breast cancer tissues and their relative non-tumor tissues was done and cDNAs of the RNAs were synthesized and then RT-qPCR was performed. Relative expression of SNHG6 202 and 203 was studied in breast cancer samples.
Results: The expression patterns of SNHG6 202 and 203 variants were different. Difference in the expression pattern of SNHG6 202 was significantly remarkable in relation to the HER2 status of tumor samples. SNHG6 203 was expressed in tumor and non-tumor tissues differentially and the expression difference was significant. Also, this transcript exhibited significant expression difference in different stages of the studied breast tumor samples.
Conclusion: It could be stated that SNHG6 203 transcript might be considered as a prognostic and staging biomarker in breast cancer studies and treatment.

Keywords

References

  1. Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci 2013; 70(24):4785-94.
  2. Rossi MN, Antonangeli F. LncRNAs: new players in apoptosis control. International Journal of Cell Biology 2014; 2014: 473857.
  3. Degirmenci U, Lei S. Role of lncRNAs in cellular aging. Front Endocrinol (Lausanne) 2016; 7:151.
  4. Zhao W, Fu H, Zhang S, Sun S, Liu Y. LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR-520d-3p/STAT3 axis. Cancer Med 2018; 7(7):3311-20.
  5. Huang Z, Ye B, Wang Z, Han J, Lin L, Shan P, et al. Inhibition of LncRNA-HRIM increases cell viability by regulating autophagy levels during hypoxia/reoxygenation in myocytes. Cell Physiol Biochem 2018; 46(4):1341-51.
  6. Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int J Cancer 2016; 139(2):269-80.
  7. Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget 2016; 7(38):61741-54.
  8. Hokii Y, Sasano Y, Sato M, Sakamoto H, Sakata K, Shingai R, et al. A small nucleolar RNA functions in rRNA processing in Caenorhabditis elegans. Nucleic Acids Res 2010; 38(17):5909-18.
  9. Kiss T. Small nucleolar RNA‐guided post‐transcriptional modification of cellular RNAs. EMBO J 2001; 20(14):3617-22.
  10. Gerbi SA, Borovjagin AV. Pre-ribosomal RNA Processing in Multicellular Organisms. Texas: Landes Bioscience; 2000-2013. p.170-98.
  11. Sloan KE, Warda AS, Sharma S, Entian KD, Lafontaine DL Bohnsack MT. Tuning the ribosome: the influence of rRNA modification on eukaryotic ribosome biogenesis and function. RNA Biol 2017; 14(9):1138-52.
  12. Gerbi SA, Borovjagin AV, Ezrokhi M, Lange TS. Ribosome biogenesis: role of small nucleolar RNA in maturation of eukaryotic rRNA. Cold Spring Harb Symp Quant Biol 2001; 66:575-90.
  13. Nazar R. Ribosomal RNA processing and ribosome biogenesis in eukaryotes. IUBMB life 2004; 56(8):457-65.
  14. Penzo M, Montanaro L. Turning uridines around: role of rRNA pseudouridylation in ribosome biogenesis and ribosomal function. Biomolecules 2018; 8(2):E38.
  15. Donati G, Montanaro L, Derenzini M. Ribosome Biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 2012; 72(7):1602-7.
  16. Pelletier J, Thomas G, Volarevic S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer 2017; 18(1):51-63.
  17. Bastide A, David A. The ribosome, (slow) beating heart of cancer (stem) cell. Oncogenesis 2018; 7(4):34.
  18. Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, et al. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett 2016; 383(2):183-94.
  19. Yang T, Zhou H, Liu P, Yan L, Yao W, Chen K, et al. lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression. Oncotarget 2017; 8(49):85353-67.
  20. Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, et al. Two novel splice variants of SOX2OT, SOX2OT‐S1, and SOX2OT‐S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem cells 2014; 32(1):126-34.
  21. Cao C, Zhang T, Zhang D, Xie L, Zou X, Lei L, et al. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene 2017; 36(8):1112-22.
  22. Yan K, Tian J, Shi W, Xia H, Zhu Y. LncRNA SNHG6 is associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through epigenetically silencing p27 and sponging miR-101-3p. Cell Physiol Biochem 2017; 42(3):999-1012.
  23. Meng Q, Yang BY, Liu B, Yang J-X, Sun Y. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p. Int J Biol Markers 2018; 33(2):148-55.
Journal of Kerman University of Medical Sciences

Volume 26, Issue 4
July and August 2019
Pages 253-259

Files

Share

How to cite

Statistics